Gaining Ground: Expanding Options for Advanced HCC - Episode 8

IMbrave-150 and HIMALAYA: Clinical Trials of Immune Checkpoint Inhibitor Combinations in HCC

, ,

The panel reviews the HIMALAYA and IMbrave-150 clinical trials of checkpoint inhibitor combination therapy strategies in advanced HCC.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Overview of Hepatocellular Carcinoma Risk Factors
    EP. 2: Review of Curative Treatment Strategies for HCC
    EP. 3: Child-Pugh Scoring System and Liver Function Assessment
    EP. 4: Therapy for Locally Advanced HCC
    EP. 5: The Advent of Systemic Therapy for HCC
    EP. 6: Immune Checkpoint Inhibitors in HCC
    EP. 7: Combination Therapy with Immune Checkpoint Inhibitors for HCC
    Now Viewing
    EP. 8: IMbrave-150 and HIMALAYA: Clinical Trials of Immune Checkpoint Inhibitor Combinations in HCC
    EP. 9: Immune Checkpoint Inhibitors and Their Effects on Liver Function
    EP. 10: Real-World Evidence on Use of Immune Checkpoint Inhibitor Combinations and Clinical Trial Endpoints
    EP. 11: Novel Strategies: Combining Systemic and Local Therapies
    EP. 12: HCC International Clinical Trials
    x